These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

602 related items for PubMed ID: 8403814

  • 21. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [Abstract] [Full Text] [Related]

  • 22. Treatment of idiopathic nephrotic syndrome with cyclosporine A.
    Meyrier A.
    J Nephrol; 1997 Nov; 10(1):14-24. PubMed ID: 9241620
    [Abstract] [Full Text] [Related]

  • 23. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.
    Peters HP, van de Kar NC, Wetzels JF.
    Neth J Med; 2008 Nov; 66(10):408-15. PubMed ID: 19011266
    [Abstract] [Full Text] [Related]

  • 24. [Nephrotic syndrome in minimal change disease (kidney), focal segmental glomerulosclerosis, and focal mesangioproliferative glomerulonephritis].
    Voznesenskaia TS, Sergeeva TV.
    Ter Arkh; 2002 Nov; 74(6):31-3. PubMed ID: 12136479
    [Abstract] [Full Text] [Related]

  • 25. [Possibilities for treating patients with the idiopathic nephrotic syndrome].
    Belovezhdov N.
    Vutr Boles; 1985 Nov; 24(4):55-63. PubMed ID: 4072170
    [Abstract] [Full Text] [Related]

  • 26. Do current recommendations for kidney biopsy in nephrotic syndrome need modifications?
    Gulati S, Sharma AP, Sharma RK, Gupta A, Gupta RK.
    Pediatr Nephrol; 2002 Jun; 17(6):404-8. PubMed ID: 12107803
    [Abstract] [Full Text] [Related]

  • 27. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
    Ferrari P, Frey FJ.
    Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
    [Abstract] [Full Text] [Related]

  • 28. Cyclosporine utilization in idiopathic nephrotic syndrome in children.
    Saeed B, Ossman MI, Sheriff S.
    Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):497-502. PubMed ID: 17186683
    [Abstract] [Full Text] [Related]

  • 29. [Membranous kidney diseases in adults].
    Sobarzo Toro M, Vilches A.
    Medicina (B Aires); 2004 Dec; 64(1):59-65. PubMed ID: 15034960
    [Abstract] [Full Text] [Related]

  • 30. [Effect of cyclosporin A on renal function in patients with glomerulonephritis].
    Heering P, Schneider A, Grabensee B, Plum J.
    Dtsch Med Wochenschr; 2001 Oct 05; 126(40):1093-8. PubMed ID: 11588659
    [Abstract] [Full Text] [Related]

  • 31. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
    Busch M, Gerth J, Ott U, Schip A, Haufe CC, Gröne HJ, Wolf G.
    Med Klin (Munich); 2008 Jul 15; 103(7):519-24. PubMed ID: 18604487
    [Abstract] [Full Text] [Related]

  • 32. Cyclosporine treatment of glomerular diseases.
    Klein M, Radhakrishnan J, Appel G.
    Annu Rev Med; 1999 Jul 15; 50():1-15. PubMed ID: 10073260
    [Abstract] [Full Text] [Related]

  • 33. [Therapy of primary chronic glomerulonephritis].
    Risler T, Braun N, Erley CM.
    Ther Umsch; 1994 Dec 15; 51(12):807-12. PubMed ID: 7784993
    [Abstract] [Full Text] [Related]

  • 34. Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study.
    Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Fukami K, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Yoshio T, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y.
    Clin Exp Nephrol; 2018 Dec 15; 22(6):1266-1280. PubMed ID: 29679356
    [Abstract] [Full Text] [Related]

  • 35. Pefloxacin as first-line treatment in nephrotic syndrome.
    Ginsburg C, Toledano D, Deray G, Vlassopoulos D, Baumelou A, Jacobs C.
    Nephrol Dial Transplant; 1994 Dec 15; 9(3):335. PubMed ID: 8052452
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
    Alexopoulos E, Papagianni A, Tsamelashvili M, Leontsini M, Memmos D.
    Nephrol Dial Transplant; 2006 Nov 15; 21(11):3127-32. PubMed ID: 16968719
    [Abstract] [Full Text] [Related]

  • 38. Partial remission of resistant nephrotic syndrome after oral galactose therapy.
    Kopač M, Meglič A, Rus RR.
    Ther Apher Dial; 2011 Jun 15; 15(3):269-72. PubMed ID: 21624074
    [Abstract] [Full Text] [Related]

  • 39. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
    Idasiak-Piechocka I, Oko A, Łochyńska-Bielecka K, Skrobańska B.
    Kidney Blood Press Res; 2009 Jun 15; 32(4):263-7. PubMed ID: 19776643
    [Abstract] [Full Text] [Related]

  • 40. Membranous glomerulopathy associated with idiopathic hypereosinophilic syndrome.
    Frigui M, Hmida MB, Jallouli M, Kechaou M, Frikha F, Bahloul Z.
    Saudi J Kidney Dis Transpl; 2010 Mar 15; 21(2):320-2. PubMed ID: 20228521
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.